← 產業報告目錄

Cerebrospinal Fluid Management Devices Market Research Report by Product (Shunts, Valve, Critical Care Products, Dural Sealants, Others), by Age Group (Pediatric, Adult, Geriatric), by End User (Hospitals, Ambulatory Settings, Research and Academic Institutes, Others), and by Region (Americas, Europe, Asia-Pacific, Middle East & Africa) Forecast till 2027

出版商 Market Research Future產業別 Healthcare & Life Sciences出版日期 2025-08-09頁數 142報告編號 MRFRHC5730CR

授權報價

Single User Price$4,950 USD
Multi User Licence (up to 10 users)$5,950 USD
Enterprisewide Price (Global Site License)$7,250 USD
洽詢購買 申請 Sample

報告摘要

Cerebrospinal Fluid Management Devices Market Research Report by Product (Shunts, Valve, Critical Care Products, Dural Sealants, Others), by Age Group (Pediatric, Adult, Geriatric), by End User (Hospitals, Ambulatory Settings, Research and Academic Institutes, Others), and by Region (Americas, Europe, Asia-Pacific, Middle East & Africa) Forecast till 2027 Market Overview The global cerebrospinal fluid management devices market is projected to reach USD 3,821.61 million by 2027, growing at a CAGR of 5.45% by the forecast year. Cerebrospinal fluid (CSF) management devices are medical tools designed to regulate and control the flow or drainage of CSF in patients with neurological conditions. They are commonly used in disorders such as hydrocephalus, brain injuries, or tumors to prevent excessive fluid buildup and maintain normal pressure in the brain and spinal cord. The global cerebrospinal fluid management devices market is being greatly influenced by the rapidly growing geriatric population. The elderly are more susceptible to nervous system diseases, i.e., Alzheimer's disease, Parkinson's disease, and stroke. They are dependent on the supply of advanced treatment. As the UN predicts the number of seniors to increase from 125 million to 425 million in 2050, the rise of age-related disorders will inevitably lead to an increase in hospital visits, subsequently raising the demand for effective CSF solutions that can help in handling the occurrence of complications and improving patient outcomes. Key Company Development Natus Medical Incorporated, in October 2017, added more strength to its portfolio via the purchase of the selected neurosurgery business assets of Integra LifeSciences. The transaction encompassed the Camino ICP monitoring product line, the US rights to Integra’s fixed pressure shunts, CSF collection systems, Codman’s DURAFORM dural graft implant, and standard EVD catheters. This acquisition allowed Natus to enhance its technological capabilities in neurosurgery and reaffirm its commitment to providing the latest solutions. By this step, the company had the possibility to be present in the global cerebrospinal fluid management devices market to a greater extent. Major Players Key players in the global cerebrospinal fluid management devices market are Medtronic PLC, Natus Medical Incorporated, B. Braun Melsungen AG, Sophysa, IRRAS AB, Möller Medical GmbH, Argi Grup, Longeviti, Integra LifeSciences, Corporation, and Anuncia. Report Attribute Details • Market Size 2019: USD 2,505.13 Million • Market Size 2027: USD 3,821.61Million • CAGR (2020-2027): 5.45% • Base Year: 2019 • Market Forecast Period: 2020-2027 Market Segmentations • By Product: Shunts - 5.26%, Critical Care Products - 5.44%. • By Age Group: Pediatric - 5.30%, Adult - 5.67%. • By End User: Hospitals - 5.41%, Ambulatory Settings - 5.71%. Regional Insights The Americas are at the forefront of the global CSF management devices market and have the greatest local strengths of a strong medical device manufacturing base, an advanced healthcare infrastructure, and a high uptake of breakthrough technologies. North America led the market in 2019 with USD 705.99 million, supported by Latin America’s contribution of USD 213.13 million. Europe is the second biggest market after the US, with the growth mainly led by strong R&D investments, positive government initiatives, and a rising awareness of neurological diseases. The likes of Germany, France, and the UK are still going from strength to strength as the main areas of innovation, which is being fostered by the associations between the manufacturers and the neurosurgeons. Europe recorded strong performance, with Western Europe at USD 543.03 million and Eastern Europe at USD 154.80 million. The Asia-Pacific region is the fastest-growing market, with the rise of healthcare expenditure being the main driver that has also led to an increase in patient awareness and investments in neurological research. The Asia-Pacific market was driven by China (USD 190.98 million), followed by Japan (USD 125.10 million) and India (USD 98.68 million). The formation of the Hydrocephalus Support Association in Australia is compelling, as it unites the research, treatment, and patient support networks, thereby improving the ecosystem. The Middle East & Africa contribute the least. The region is showing gradual progress, particularly in the GCC. Rising healthcare investments, favorable regulatory reforms, and partnerships between global manufacturers and regional hospitals are opening growth opportunities. Countries such as Saudi Arabia are positioning themselves as medical hubs, enhancing the adoption of advanced neurosurgical technologies.
目錄 Table of Contents
TABLE OF CONTENTS 1 EXECUTIVE SUMMARY 17 1.1 OVERVIEW 17 1.2 MARKET SYNOPSIS 17 2 MARKET INTRODUCTION 18 2.1 SCOPE OF THE STUDY 18 2.2 RESEARCH OBJECTIVE 18 2.3 LIST OF ASSUMPTIONS 18 3 RESEARCH METHODOLOGY 20 3.1 OVERVIEW 20 3.2 DATA MINING 20 3.3 SECONDARY RESEARCH 21 3.4 PRIMARY RESEARCH 22 3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 22 3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 23 3.5 FORECASTING TECHNIQUES 23 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 24 3.6.1 BOTTOM-UP APPROACH 25 3.6.2 TOP-DOWN APPROACH 25 3.7 DATA TRIANGULATION 26 3.8 VALIDATION 26 4 MARKET DYNAMICS 27 4.1 OVERVIEW 27 4.2 DRIVERS 28 4.2.1 INCREASING PREVALENCE OF HYDROCEPHALUS & SUBSEQUENT RISE IN NUMBER OF SHUNTING PROCEDURES 28 4.2.2 GROWING GERIATRIC POPULATION 28 4.3 RESTRAINT 29 4.3.1 COMPLICATIONS RELATED TO CSF SHUNT SYSTEMS 29 4.4 OPPORTUNITY 29 4.4.1 ENTERING DEVELOPING MARKETS 29 4.5 COVID-19 IMPACT ANALYSIS 30 5 MARKET FACTOR ANALYSIS 31 5.1 VALUE CHAIN ANALYSIS 31 5.1.1 R&D AND DESIGNING 32 5.1.2 MANUFACTURING 32 5.1.3 DISTRIBUTION 32 5.1.4 MARKETING AND SALES 32 5.1.5 POST-SALES MONITORING 32 5.2 PORTER’S FIVE FORCES MODEL 33 5.2.1 THREAT OF NEW ENTRANTS 33 5.2.2 BARGAINING POWER OF SUPPLIERS 34 5.2.3 BARGAINING POWER OF BUYERS 34 5.2.4 THREAT OF SUBSTITUTES 34 5.2.5 INTENSITY OF RIVALRY 34 6 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT 35 6.1 OVERVIEW 35 6.2 SHUNTS 36 6.3 CRITICAL CARE PRODUCTS 38 6.4 DURAL SEALANTS 39 6.5 OTHERS 39 7 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP 40 7.1 OVERVIEW 40 7.2 PEDIATRIC 41 7.3 ADULT 41 7.4 GERIATRIC 42 8 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER 43 8.1 OVERVIEW 43 8.2 HOSPITALS 44 8.3 AMBULATORY SETTINGS 44 8.4 RESEARCH & ACADEMIC INSTITUTES 45 9 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY REGION 46 9.1 OVERVIEW 46 9.2 AMERICAS 48 9.2.1 NORTH AMERICA 51 9.2.1.1 US 54 9.2.1.2 CANADA 56 9.2.2 LATIN AMERICA 59 9.3 EUROPE 62 9.3.1 WESTERN EUROPE 65 9.3.1.1 GERMANY 68 9.3.1.2 FRANCE 71 9.3.1.3 REST OF WESTERN EUROPE 73 9.3.1.4 UK 75 9.3.1.5 ITALY 78 9.3.1.6 SPAIN 80 9.3.2 EASTERN EUROPE 82 9.4 ASIA-PACIFIC 85 9.4.1 CHINA 88 9.4.2 JAPAN 90 9.4.3 REST OF ASIA PACIFIC 93 9.4.4 INDIA 95 9.4.5 SOUTH KOREA 97 9.4.6 AUSTRALIA 100 9.5 MIDDLE EAST & AFRICA 103 9.5.1 MIDDLE EAST 106 9.5.2 AFRICA 108 10 COMPETITIVE LANDSCAPE 111 10.1 OVERVIEW 111 10.2 COMPETITIVE BENCHMARKING 112 10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET 113 10.4 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET 114 10.5 KEY DEVELOPMENT ANALYSIS 114 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 115 10.6.1 ACQUISITION ACTIVITIES 115 10.6.2 EXPANSIONS 115 10.6.3 PRODUCT LAUNCHES 115 10.7 FINANCIAL MATRIX 116 10.7.1 SALES 116 10.7.2 R&D EXPENDITURE 116 11 COMPANY PROFILES 117 11.1 MEDTRONIC PLC 117 11.1.1 COMPANY OVERVIEW 117 11.1.2 FINANCIAL OVERVIEW 118 11.1.3 PRODUCTS/SERVICES OFFERED 118 11.1.4 KEY DEVELOPMENTS 119 11.1.5 SWOT ANALYSIS 119 11.1.6 KEY STRATEGIES 119 11.2 NATUS MEDICAL INCORPORATED 120 11.2.1 COMPANY OVERVIEW 120 11.2.2 FINANCIAL OVERVIEW 120 11.2.3 PRODUCTS/SERVICES OFFERED 121 11.2.4 KEY DEVELOPMENTS 121 11.2.5 SWOT ANALYSIS 122 11.2.6 KEY STRATEGIES 122 11.3 B. BRAUN MELSUNGEN AG 123 11.3.1 COMPANY OVERVIEW 123 11.3.2 FINANCIAL OVERVIEW 123 11.3.3 PRODUCTS/SERVICES OFFERED 124 11.3.4 KEY DEVELOPMENTS 124 11.3.5 SWOT ANALYSIS 125 11.3.6 KEY STRATEGIES 125 11.4 SOPHYSA 126 11.4.1 COMPANY OVERVIEW 126 11.4.2 FINANCIAL OVERVIEW 126 11.4.3 PRODUCTS/SERVICES OFFERED 126 11.4.4 KEY DEVELOPMENTS 126 11.4.5 SWOT ANALYSIS 127 11.4.6 KEY STRATEGIES 127 11.5 IRRAS AB 128 11.5.1 COMPANY OVERVIEW 128 11.5.2 FINANCIAL OVERVIEW 128 11.5.3 PRODUCTS/SERVICES OFFERED 129 11.5.4 KEY DEVELOPMENTS 129 11.5.5 SWOT ANALYSIS 129 11.5.6 KEY STRATEGIES 129 11.6 MÖLLER MEDICAL GMBH 130 11.6.1 COMPANY OVERVIEW 130 11.6.2 FINANCIAL OVERVIEW 130 11.6.3 PRODUCTS/SERVICES OFFERED 130 11.6.4 KEY DEVELOPMENTS 130 11.6.5 SWOT ANALYSIS 130 11.6.6 KEY STRATEGIES 131 11.7 ARGI GRUP 132 11.7.1 COMPANY OVERVIEW 132 11.7.2 FINANCIAL OVERVIEW 132 11.7.3 PRODUCTS/SERVICES OFFERED 132 11.7.4 KEY DEVELOPMENTS 132 11.7.5 SWOT ANALYSIS 133 11.7.6 KEY STRATEGIES 133 11.8 LONGEVITI 134 11.8.1 COMPANY OVERVIEW 134 11.8.2 FINANCIAL OVERVIEW 134 11.8.3 PRODUCTS/SERVICES OFFERED 134 11.8.4 KEY DEVELOPMENTS 134 11.8.5 SWOT ANALYSIS 135 11.8.6 KEY STRATEGIES 135 11.9 INTEGRA LIFESCIENCES CORPORATION 136 11.9.1 COMPANY OVERVIEW 136 11.9.2 FINANCIAL OVERVIEW 136 11.9.3 PRODUCTS/SERVICES OFFERED 137 11.9.4 KEY DEVELOPMENTS 137 11.9.5 SWOT ANALYSIS 138 11.9.6 KEY STRATEGIES 138 11.10 ANUNCIA 139 11.10.1 COMPANY OVERVIEW 139 11.10.2 FINANCIAL OVERVIEW 139 11.10.3 PRODUCTS/SERVICES OFFERED 139 11.10.4 KEY DEVELOPMENTS 139 11.10.5 SWOT ANALYSIS 140 11.10.6 KEY STRATEGIES 140 12 APPENDIX 141 12.1 REFERENCES 141 12.2 RELATED REPORTS 141
圖表清單 List of Tables & Figures
LIST OF TABLES TABLE 1 LIST OF ASSUMPTIONS 18 TABLE 2 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT 2017-2027 (USD MILLION) 36 TABLE 3 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS, BY REGION 2017-2027 (USD MILLION) 37 TABLE 4 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 37 TABLE 5 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 37 TABLE 6 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCTS, BY REGION 2017-2027 (USD MILLION) 38 TABLE 7 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCTS, BY TYPE 2017-2027 (USD MILLION) 38 TABLE 8 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 38 TABLE 9 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR DURAL SEALANTS, BY REGION 2017-2027 (USD MILLION) 39 TABLE 10 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP 2017-2027 (USD MILLION) 41 TABLE 11 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR PEDIATRIC, BY REGION 2017-2027 (USD MILLION) 41 TABLE 12 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR ADULT, BY REGION 2017-2027 (USD MILLION) 42 TABLE 13 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR GERIATRIC, BY REGION 2017-2027 (USD MILLION) 42 TABLE 14 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER 2017-2027 (USD MILLION) 44 TABLE 15 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR HOSPITALS, BY REGION 2017-2027 (USD MILLION) 44 TABLE 16 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR AMBULATORY SETTINGS, BY REGION 2017-2027 (USD MILLION) 45 TABLE 17 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION 2017-2027 (USD MILLION) 45 TABLE 18 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY REGION, 2019 (%) 47 TABLE 19 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY REGION 2017-2027 (USD MILLION) 47 TABLE 20 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY REGION, 2017-2027 (USD MILLION) 48 TABLE 21 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 49 TABLE 22 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 49 TABLE 23 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 49 TABLE 24 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 50 TABLE 25 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 50 TABLE 26 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 50 TABLE 27 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 51 TABLE 28 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY COUNTRY, 2017-2027 (USD MILLION) 51 TABLE 29 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 52 TABLE 30 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 52 TABLE 31 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 52 TABLE 32 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 53 TABLE 33 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 53 TABLE 34 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 53 TABLE 35 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 54 TABLE 36 US: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 54 TABLE 37 US: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 54 TABLE 38 US: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 55 TABLE 39 US: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 55 TABLE 40 US: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 55 TABLE 41 US: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 56 TABLE 42 US: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 56 TABLE 43 CANADA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 56 TABLE 44 CANADA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 57 TABLE 45 CANADA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 57 TABLE 46 CANADA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 57 TABLE 47 CANADA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 58 TABLE 48 CANADA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 58 TABLE 49 CANADA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 58 TABLE 50 LATIN AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 59 TABLE 51 LATIN AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 59 TABLE 52 LATIN AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 59 TABLE 53 LATIN AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 60 TABLE 54 LATIN AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 60 TABLE 55 LATIN AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 60 TABLE 56 LATIN AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 61 TABLE 57 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY REGION, 2017-2027 (USD MILLION) 62 TABLE 58 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 63 TABLE 59 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 63 TABLE 60 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 63 TABLE 61 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 64 TABLE 62 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 64 TABLE 63 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 64 TABLE 64 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 65 TABLE 65 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY COUNTRY 2017-2027 (USD MILLION) 66 TABLE 66 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 66 TABLE 67 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 66 TABLE 68 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 67 TABLE 69 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 67 TABLE 70 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 67 TABLE 71 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 68 TABLE 72 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 68 TABLE 73 GERMANY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 68 TABLE 74 GERMANY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 69 TABLE 75 GERMANY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 69 TABLE 76 GERMANY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 69 TABLE 77 GERMANY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 70 TABLE 78 GERMANY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 70 TABLE 79 GERMANY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 70 TABLE 80 FRANCE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 71 TABLE 81 FRANCE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 71 TABLE 82 FRANCE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 71 TABLE 83 FRANCE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 72 TABLE 84 FRANCE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 72 TABLE 85 FRANCE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 72 TABLE 86 FRANCE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 73 TABLE 87 REST OF WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 73 TABLE 88 REST OF WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 73 TABLE 89 REST OF WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 74 TABLE 90 REST OF WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 74 TABLE 91 REST OF WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 74 TABLE 92 REST OF WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 75 TABLE 93 REST OF WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 75 TABLE 94 UK: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 75 TABLE 95 UK: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 76 TABLE 96 UK: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 76 TABLE 97 UK: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 76 TABLE 98 UK: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 77 TABLE 99 UK: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 77 TABLE 100 UK: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 77 TABLE 101 ITALY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 78 TABLE 102 ITALY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 78 TABLE 103 ITALY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 78 TABLE 104 ITALY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 79 TABLE 105 ITALY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 79 TABLE 106 ITALY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 79 TABLE 107 ITALY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 80 TABLE 108 SPAIN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 80 TABLE 109 SPAIN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 80 TABLE 110 SPAIN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 81 TABLE 111 SPAIN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 81 TABLE 112 SPAIN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 81 TABLE 113 SPAIN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 82 TABLE 114 SPAIN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 82 TABLE 115 EASTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 82 TABLE 116 EASTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 83 TABLE 117 EASTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 83 TABLE 118 EASTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 83 TABLE 119 EASTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 84 TABLE 120 EASTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 84 TABLE 121 EASTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 84 TABLE 122 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY COUNTRY, 2017-2027 (USD MILLION) 85 TABLE 123 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 86 TABLE 124 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 86 TABLE 125 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 86 TABLE 126 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 87 TABLE 127 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 87 TABLE 128 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 87 TABLE 129 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 88 TABLE 130 CHINA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 88 TABLE 131 CHINA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 88 TABLE 132 CHINA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 89 TABLE 133 CHINA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 89 TABLE 134 CHINA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 89 TABLE 135 CHINA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 90 TABLE 136 CHINA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 90 TABLE 137 JAPAN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 90 TABLE 138 JAPAN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 91 TABLE 139 JAPAN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 91 TABLE 140 JAPAN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 91 TABLE 141 JAPAN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 92 TABLE 142 JAPAN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 92 TABLE 143 JAPAN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 92 TABLE 144 REST OF ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 93 TABLE 145 REST OF ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 93 TABLE 146 REST OF ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 93 TABLE 147 REST OF ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 94 TABLE 148 REST OF ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 94 TABLE 149 REST OF ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 94 TABLE 150 REST OF ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 95 TABLE 151 INDIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 95 TABLE 152 INDIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 95 TABLE 153 INDIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 96 TABLE 154 INDIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 96 TABLE 155 INDIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 96 TABLE 156 INDIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 97 TABLE 157 INDIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 97 TABLE 158 SOUTH KOREA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 97 TABLE 159 SOUTH KOREA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 98 TABLE 160 SOUTH KOREA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 98 TABLE 161 SOUTH KOREA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 98 TABLE 162 SOUTH KOREA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 99 TABLE 163 SOUTH KOREA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 99 TABLE 164 SOUTH KOREA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 99 TABLE 165 AUSTRALIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 100 TABLE 166 AUSTRALIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 100 TABLE 167 AUSTRALIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 100 TABLE 168 AUSTRALIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 101 TABLE 169 AUSTRALIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 101 TABLE 170 AUSTRALIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 101 TABLE 171 AUSTRALIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 102 TABLE 172 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY REGION, 2017-2027 (USD MILLION) 103 TABLE 173 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 104 TABLE 174 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 104 TABLE 175 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 104 TABLE 176 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 105 TABLE 177 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 105 TABLE 178 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 105 TABLE 179 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 106 TABLE 180 MIDDLE EAST: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 106 TABLE 181 MIDDLE EAST: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 106 TABLE 182 MIDDLE EAST: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 107 TABLE 183 MIDDLE EAST: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 107 TABLE 184 MIDDLE EAST: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 107 TABLE 185 MIDDLE EAST: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 108 TABLE 186 MIDDLE EAST: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 108 TABLE 187 AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 108 TABLE 188 AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION) 109 TABLE 189 AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION) 109 TABLE 190 AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION) 109 TABLE 191 AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 110 TABLE 192 AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION) 110 TABLE 193 AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION) 110 TABLE 194 BENCHMARKING OF MAJOR COMPETITORS 112 TABLE 195 ACTIVE PLAYERS IN THE GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET 114 TABLE 196 ACQUISITION ACTIVITIES 115 TABLE 197 EXPANSIONS 115 TABLE 198 PRODUCT LAUNCHES 115 TABLE 199 MEDTRONIC PLC: PRODUCTS/SERVICES OFFERED 118 TABLE 200 NATUS MEDICAL INCORPORATED: PRODUCTS/SERVICES OFFERED 121 TABLE 201 NATUS MEDICAL INCORPORATED: KEY DEVELOPMENTS 121 TABLE 202 B. BRAUN MELSUNGEN AG: PRODUCTS/SERVICES OFFERED 124 TABLE 203 B. BRAUN MELSUNGEN AG: KEY DEVELOPMENTS 124 TABLE 204 SOPHYSA: PRODUCTS/SERVICES OFFERED 126 TABLE 205 IRRAS AB: PRODUCTS/SERVICES OFFERED 129 TABLE 206 IRRAS AB: KEY DEVELOPMENTS 129 TABLE 207 MÖLLER MEDICAL GMBH: PRODUCTS/SERVICES OFFERED 130 TABLE 208 ARGI GRUP: PRODUCTS/SERVICES OFFERED 132 TABLE 209 LONGEVITI: PRODUCTS/SERVICES OFFERED 134 TABLE 210 LONGEVITI: KEY DEVELOPMENTS 134 TABLE 211 INTEGRA LIFESCIENCES CORPORATION: PRODUCTS/SERVICES OFFERED 137 TABLE 212 INTEGRA LIFESCIENCES CORPORATION: KEY DEVELOPMENTS 137 TABLE 213 ANUNCIA: PRODUCTS/SERVICES OFFERED 139 TABLE 214 ANUNCIA: KEY DEVELOPMENTS 139 LIST OF FIGURES FIGURE 1 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET STRUCTURE 19 FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES 25 FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET 27 FIGURE 4 DRIVER IMPACT ANALYSIS 28 FIGURE 5 RESTRAINT IMPACT ANALYSIS 29 FIGURE 6 VALUE CHAIN ANALYSIS: GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET 31 FIGURE 7 PORTER’S FIVE FORCES ANALYSIS: GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET 33 FIGURE 8 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT 2019 (%) 35 FIGURE 9 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT 2019 & 2027 (USD MILLION) 36 FIGURE 10 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP 2019 (%) 40 FIGURE 11 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP 2019 & 2027 (USD MILLION) 40 FIGURE 12 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER 2019 (%) 43 FIGURE 13 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER 2019 & 2027 (USD MILLION) 43 FIGURE 14 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY REGION 2019 & 2027 (USD MILLION) 46 FIGURE 15 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY REGION 2019 (%) 48 FIGURE 16 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY COUNTRY 2019 (%) 51 FIGURE 17 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY REGION 2019 (%) 62 FIGURE 18 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY COUNTRY 2019 (%) 65 FIGURE 19 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY REGION 2019 (%) 85 FIGURE 20 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY REGION 2019 (%) 103 FIGURE 21 MAJOR MANUFACTURERS IN THE GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, MARKET SHARE (2019) 111 FIGURE 22 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET 113 FIGURE 23 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, COMPETITIVE LANDSCAPE 114 FIGURE 24 SALES 116 FIGURE 25 R&D EXPENDITURE 116 FIGURE 26 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT 118 FIGURE 27 MEDTRONIC PLC: SWOT ANALYSIS 119 FIGURE 28 NATUS MEDICAL INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT 120 FIGURE 29 NATUS MEDICAL INCORPORATED: SWOT ANALYSIS 122 FIGURE 30 B. BRAUN MELSUNGEN AG: FINANCIAL OVERVIEW 123 FIGURE 31 B. BRAUN MELSUNGEN AG: SWOT ANALYSIS 125 FIGURE 32 SOPHYSA: SWOT ANALYSIS 127 FIGURE 33 IRRAS AB: FINANCIAL OVERVIEW SNAPSHOT 128 FIGURE 34 IRRAS AB: SWOT ANALYSIS 129 FIGURE 35 MÖLLER MEDICAL GMBH: SWOT ANALYSIS 130 FIGURE 36 ARGI GRUP: SWOT ANALYSIS 133 FIGURE 37 LONGEVITI: SWOT ANALYSIS 135 FIGURE 38 INTEGRA LIFESCIENCES CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 136 FIGURE 39 INTEGRA LIFESCIENCES CORPORATION: SWOT ANALYSIS 138 FIGURE 40 ANUNCIA: SWOT ANALYSIS 140

提及公司

Medtronic PLCNatus Medical IncorporatedB. Braun Melsungen AGSophysaIRRAS ABMöller Medical GmbHArgi GrupLongevitiIntegra LifeSciencesCorporationAnuncia

同分類最新報告(醫療與生命科學)

量子訊息有限公司為 Market Research Future 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們